Article Information
History
- August 8, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Minjie Li, MSc.1,*,
- Juan Yang, Ph.D.2,*,
- Lin Wang, MSc.3,*,
- Qianhui Wu, MPH2,
- Zhiwei Wu, MSc.1,
- Wen Zheng, BSc2,
- Lei Wang, MSc.4,
- Wanying Lu, BSc2,
- Xiaowei Deng, MSc2,
- Cheng Peng, BSc2,
- Bihua Han, MSc.1,
- Yuliang Zhao, MSc.1,†,#,
- Hongjie Yu, M.D. Ph.D.2,5,6,†,# and
- Weidong Yin, MBA7,†,#
- 1Hebei Center for Disease Control and Prevention, Shijiazhuang, China
- 2School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China
- 3R&D Department, Sinovac Life Sciences Co., Ltd., Beijing, China
- 4Department of Clinical Research, Sinovac Biotech Co., Ltd., Beijing, China
- 5Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China
- 6Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China
- 7General Manager’s Office. Sinovac Biotech Co., Ltd., Beijing, China
- ↵#Corresponding to
Yuliang Zhao, Hebei Center for Disease Control and Prevention, Shijiazhuang 050021, China, Email: Yuliang_zh1{at}163.com; Hongjie Yu, School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai 200032, China, Email: yhj{at}fudan.edu.cn; Weidong Yin, Sinovac Biotech Co., Ltd., Beijing 100085, China. Email: yinwd{at}sinovac.com.